These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 28769582)

  • 1.
    St Sauver JL; Olson JE; Roger VL; Nicholson WT; Black JL; Takahashi PY; Caraballo PJ; Bell EJ; Jacobson DJ; Larson NB; Bielinski SJ
    Pharmgenomics Pers Med; 2017; 10():217-227. PubMed ID: 28769582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex Differences in Associations Between CYP2D6 Phenotypes and Response to Opioid Analgesics.
    Lopes GS; Bielinski SJ; Moyer AM; Black Iii JL; Jacobson DJ; Jiang R; Larson NB; St Sauver JL
    Pharmgenomics Pers Med; 2020; 13():71-79. PubMed ID: 32214840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of CYP2D6 Pharmacogenomic Status on Pain Control Among Opioid-Treated Oncology Patients.
    Reizine N; Danahey K; Schierer E; Liu P; Middlestadt M; Ludwig J; Truong TM; van Wijk XMR; Yeo KJ; Malec M; Ratain MJ; O'Donnell PH
    Oncologist; 2021 Nov; 26(11):e2042-e2052. PubMed ID: 34423496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utilization of pharmacogenomics and therapeutic drug monitoring for opioid pain management.
    Jannetto PJ; Bratanow NC
    Pharmacogenomics; 2009 Jul; 10(7):1157-67. PubMed ID: 19604091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-drug-gene interaction risk among opioid users in the U.S. Department of Veterans Affairs.
    Chanfreau-Coffinier C; Tuteja S; Hull LE; MacDonald S; Efimova O; Bates J; Voora D; Oslin DW; DuVall SL; Lynch JA
    Pain; 2022 Dec; 163(12):2390-2397. PubMed ID: 35319502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of
    Merchant S; Prows CA; Yang F; Ding L; MacDonald J; Zhang X; Sadhasivam S; Garcia V; Sturm P; Chidambaran V
    Ann Transl Med; 2022 Dec; 10(23):1262. PubMed ID: 36618804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CYP2D6 predicted metabolizer status and safety in adult patients with attention-deficit hyperactivity disorder participating in a large placebo-controlled atomoxetine maintenance of response clinical trial.
    Fijal BA; Guo Y; Li SG; Ahl J; Goto T; Tanaka Y; Nisenbaum LK; Upadhyaya HP
    J Clin Pharmacol; 2015 Oct; 55(10):1167-74. PubMed ID: 25919121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased risk of hospitalization for ultrarapid metabolizers of cytochrome P450 2D6.
    Takahashi PY; Ryu E; Pathak J; Jenkins GD; Batzler A; Hathcock MA; Black JL; Olson JE; Cerhan JR; Bielinski SJ
    Pharmgenomics Pers Med; 2017; 10():39-47. PubMed ID: 28243137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-gene and drug-drug interactions associated with tramadol and codeine therapy in the INGENIOUS trial.
    Fulton CR; Zang Y; Desta Z; Rosenman MB; Holmes AM; Decker BS; Zhang Y; T Callaghan J; Pratt VM; Levy KD; Gufford BT; Dexter PR; Skaar TC; Eadon MT
    Pharmacogenomics; 2019 Apr; 20(6):397-408. PubMed ID: 30784356
    [No Abstract]   [Full Text] [Related]  

  • 10. CYP2D6 Expression in Veterans Experiencing Opioid Overdose: A Postmortem Review.
    Boyle J; Stock CJ
    Pharmgenomics Pers Med; 2020; 13():289-293. PubMed ID: 32848444
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Dagostino C; Allegri M; Napolioni V; D'Agnelli S; Bignami E; Mutti A; van Schaik RH
    Pharmgenomics Pers Med; 2018; 11():179-191. PubMed ID: 30425549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Pharmacogenomic Information on Values of Care and Quality of Life Associated with Codeine and Tramadol-Related Adverse Drug Events.
    Zhu Y; Lopes GS; Bielinski SJ; Borah BJ; Larson NB; Moyer AM; Olson JE; Wang L; Weinshilboum R; St Sauver JL
    Mayo Clin Proc Innov Qual Outcomes; 2021 Feb; 5(1):35-45. PubMed ID: 33718782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphisms in CYP2D6 duplication-negative individuals with the ultrarapid metabolizer phenotype: a role for the CYP2D6*35 allele in ultrarapid metabolism?
    Løvlie R; Daly AK; Matre GE; Molven A; Steen VM
    Pharmacogenetics; 2001 Feb; 11(1):45-55. PubMed ID: 11207030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CYP2D6-guided opioid therapy improves pain control in CYP2D6 intermediate and poor metabolizers: a pragmatic clinical trial.
    Smith DM; Weitzel KW; Elsey AR; Langaee T; Gong Y; Wake DT; Duong BQ; Hagen M; Harle CA; Mercado E; Nagoshi Y; Newsom K; Wright A; Rosenberg EI; Starostik P; Clare-Salzler MJ; Schmidt SO; Fillingim RB; Johnson JA; Cavallari LH
    Genet Med; 2019 Aug; 21(8):1842-1850. PubMed ID: 30670877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preventing opioid-related deaths in children undergoing surgery.
    Sadhasivam S; Myer CM
    Pain Med; 2012 Jul; 13(7):982-3; author reply 984. PubMed ID: 22694279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implementing a pragmatic clinical trial to tailor opioids for acute pain on behalf of the IGNITE ADOPT PGx investigators.
    Cavallari LH; Cicali E; Wiisanen K; Fillingim RB; Chakraborty H; Myers RA; Blake KV; Asiyanbola B; Baye JF; Bronson WH; Cook KJ; Elwood EN; Gray CF; Gong Y; Hines L; Kannry J; Kucher N; Lynch S; Nguyen KA; Obeng AO; Pratt VM; Prieto HA; Ramos M; Sadeghpour A; Singh R; Rosenman M; Starostik P; Thomas CD; Tillman E; Dexter PR; Horowitz CR; Orlando LA; Peterson JF; Skaar TC; Van Driest SL; Volpi S; Voora D; Parvataneni HK; Johnson JA;
    Clin Transl Sci; 2022 Oct; 15(10):2479-2492. PubMed ID: 35899435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of CYP2D6 genotype and response to tetrabenazine.
    Mehanna R; Hunter C; Davidson A; Jimenez-Shahed J; Jankovic J
    Mov Disord; 2013 Feb; 28(2):210-5. PubMed ID: 23280482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CYP2D6 polymorphisms and codeine analgesia in postpartum pain management: a pilot study.
    VanderVaart S; Berger H; Sistonen J; Madadi P; Matok I; Gijsen VM; de Wildt SN; Taddio A; Ross CJ; Carleton BC; Hayden MR; Koren G
    Ther Drug Monit; 2011 Aug; 33(4):425-32. PubMed ID: 21743374
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.